Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

281 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A randomized controlled trial comparing the GLP-1 receptor agonist liraglutide to a sulphonylurea as add on to metformin in patients with established type 2 diabetes during Ramadan: the Treat 4 Ramadan Trial.
Brady EM, Davies MJ, Gray LJ, Saeed MA, Smith D, Hanif W, Khunti K. Brady EM, et al. Among authors: gray lj. Diabetes Obes Metab. 2014 Jun;16(6):527-36. doi: 10.1111/dom.12249. Epub 2014 Jan 26. Diabetes Obes Metab. 2014. PMID: 24373063 Clinical Trial.
Guidelines for managing diabetes in Ramadan.
Ali S, Davies MJ, Brady EM, Gray LJ, Khunti K, Beshyah SA, Hanif W. Ali S, et al. Among authors: gray lj. Diabet Med. 2016 Oct;33(10):1315-29. doi: 10.1111/dme.13080. Epub 2016 Feb 25. Diabet Med. 2016. PMID: 26802436 Review.
Rationale and design of the randomised controlled trial to assess the impact of liraglutide on cardiac function and structure in young adults with type 2 diabetes (the LYDIA study).
Htike ZZ, Yates T, Brady EM, Webb D, Gray LJ, Swarbrick D, McCann GP, Khunti K, Davies MJ. Htike ZZ, et al. Among authors: gray lj. Cardiovasc Diabetol. 2016 Jul 21;15(1):102. doi: 10.1186/s12933-016-0421-6. Cardiovasc Diabetol. 2016. PMID: 27440110 Free PMC article. Clinical Trial.
Assessment of response rates and yields for Two opportunistic Tools for Early detection of Non-diabetic hyperglycaemia and Diabetes (ATTEND). A randomised controlled trial and cost-effectiveness analysis.
Khunti K, Gillies CL, Dallosso H, Brady EM, Gray LJ, Kilgallen G, Willis A, Zafar A, Davies MJ. Khunti K, et al. Among authors: gray lj. Diabetes Res Clin Pract. 2016 Aug;118:12-20. doi: 10.1016/j.diabres.2016.04.054. Epub 2016 May 6. Diabetes Res Clin Pract. 2016. PMID: 27485852 Free article. Clinical Trial.
Realising the full potential of data-enabled trials in the UK: a call for action.
Sydes MR, Barbachano Y, Bowman L, Denwood T, Farmer A, Garfield-Birkbeck S, Gibson M, Gulliford MC, Harrison DA, Hewitt C, Logue J, Navaie W, Norrie J, O'Kane M, Quint JK, Rycroft-Malone J, Sheffield J, Smeeth L, Sullivan F, Tizzard J, Walker P, Wilding J, Williamson PR, Landray M, Morris A, Walker RR, Williams HC, Valentine J; Data Enabled Trials Group Workshop Group members. Sydes MR, et al. BMJ Open. 2021 Jun 16;11(6):e043906. doi: 10.1136/bmjopen-2020-043906. BMJ Open. 2021. PMID: 34135032 Free PMC article. Review.
Non-pharmacological interventions to improve cardiovascular risk factors in people with diabetic foot disease: A systematic review and meta-analysis.
Highton P, Almaqhawi A, Oroko M, Sathanapally H, Gray L, Davies M, Webb D, Game F, Petrie J, Tesfaye S, Valabhji J, Gillies C, Khunti K. Highton P, et al. Diabetes Res Clin Pract. 2024 Mar;209:111590. doi: 10.1016/j.diabres.2024.111590. Epub 2024 Feb 24. Diabetes Res Clin Pract. 2024. PMID: 38403175 Free article. Review.
281 results